Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence

Recruiting Observational Study
Bladder Cancer Comorbidity Deep Learning
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Clinician and the multidisciplinary team meeting in oncologic urology (MMO) play a key-role in the decision making. An unexplained surgeon attributable variance, probably linked to the subjective "eyeball test" effect, was identified as a strongest factor underlying non-compliance with guide line recommendations in the management of bladder cancer. So high-quality studies that identify barriers an…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years and older * Patient treated by radical cystectomy for bladder cancer Exclusion Criteria: * Computed tomography/magnetic resonance evidence of distant metastases.
Contacts

Fabien SAINT, Pr

03 22 45 59 52

saint-fabien@chu-amiens.fr

CONTACT